52 results on '"Nguyen, Mindie H."'
Search Results
2. Sarcopenia in cirrhosis: epidemiology, diagnosis, management and prognosis
3. A population-based US study of hepatitis C diagnosis rate
4. A population-based US study of hepatitis C diagnosis rate
5. Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation
6. Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients
7. Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis
8. Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium
9. Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium
10. Only one-third of hepatocellular carcinoma cases are diagnosed via screening or surveillance: a systematic review and meta-analysis
11. Serum Aminotransferase Flares in Pregnant and Postpartum Women With Current or Prior Treatment for Chronic Hepatitis B
12. Increasing co-morbidities in chronic hepatitis B patients: experience in primary care and referral practices during 2000–2015
13. Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment: Do direct‐acting antiviral regimens matter?
14. Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta‐analysis of a complex issue
15. Management of Chronic Hepatitis B in Pregnancy
16. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium
17. Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease
18. Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States
19. Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis
20. Alternative Therapies for Chronic Hepatitis B Patients With Partial Virological Response to Standard Entecavir Monotherapy
21. Effects of Cirrhosis on Short-term and Long-term Survival of Patients With Hepatitis B–related Hepatocellular Carcinoma
22. Safety and efficacy of entecavir in adefovir-experienced patients
23. Incidence of Hepatocellular Carcinoma (HCC) in a US Cohort of Chronic Hepatitis B (CHB) Patients by Age, Gender, Cirrhosis and Antiviral Treatment Status: 232
24. Mutations in HBV DNA Polymerase Associated With Nucleos(t)ide Resistance Are Rare in Treatment-naive Patients
25. Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis and Systematic Review
26. Approximately one-half of patients with early-stage hepatocellular carcinoma meeting Milan criteria did not receive local tumor destructive or curative surgery in the post-MELD exception era
27. Treating Hepatitis C in Lower-Income Countries
28. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: Results from the surveillance, epidemiology, and end results registry
29. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update
30. Prevention of Mother-to-Child Transmission of Hepatitis B Virus: Is Elective Cesarean Section in Highly Viremic Mothers an Appropriate Adjunct to Immunoprophylaxis?
31. Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice
32. Treatment Eligibility of Patients With Chronic Hepatitis B Initially Ineligible for Therapy
33. Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral Etiologies
34. Disease Presentation and Treatment in Patients with Hepatocellular Carcinoma (HCC) Associated with Hepatitis B Virus (HBV/HCC) and Patients with Hepatitis C Virus Associated HCC (HCV/HCC): 947
35. Incidence and Risk Factors in the Development of Hepatocellular Carcinoma (HCC) in Non-Cirrhotic and Cirrhotic Patients with Chronic Hepatitis B (CHB): Results of a Multicenter U.S. Cohort Study: 593
36. Clinical Characteristics and Treatment in Asian and Non-Asians with Hepatocellular Carcinoma (HCC): 563
37. Higher rates of hepatitis B surface antigen (HBsAg) seroclearance in males and in hepatitis B e-antigen negative chronic hepatitis B (CHB) among treatment naïve patients in a large multicenter U.S. cohort study: 328
38. Undertreatment of Asian Chronic Hepatitis B Patients on the Basis of Standard Guidelines: A Community-Based Study
39. Medication Nonadherence with Long-Term Management of Patients with Hepatitis B e antigen-Negative Chronic Hepatitis B
40. Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection
41. Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score
42. Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery
43. Randomized Controlled Trial of Pegylated Interferon-Alfa 2a and Ribavirin in Treatment-Naive Chronic Hepatitis C Genotype 6
44. Adherence to Screening for Hepatocellular Carcinoma Among Patients with Cirrhosis or Chronic Hepatitis B in a Community Setting
45. Histological Disease in Asian-Americans With Chronic Hepatitis B, High Hepatitis B Virus DNA, and Normal Alanine Aminotransferase Levels
46. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil#
47. Prevalence of Colorectal Neoplasms in Asian Americans
48. Low Proportion of Barrettʼs Esophagus in Asian Americans
49. Significant Prevalence of Histologic Disease in Patients With Chronic Hepatitis B and Mildly Elevated Serum Alanine Aminotransferase Levels
50. Higher Rate of Sustained Virologic Response in Chronic Hepatitis C Genotype 6 Treated With 48 Weeks Versus 24 Weeks of Peginterferon Plus Ribavirin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.